Condition
Pancreatic Neuroendocrine Tumor clinical trials and research
Research outlook What's coming for Neuroendocrine tumors: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 9 Pancreatic Neuroendocrine Tumor clinical trials that are recruiting, at sites in 25 countries (most in China (4), United States (3), Italy (2)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 25Countries
Newest Pancreatic Neuroendocrine Tumor clinical trials
All recruiting trials (9)
-
AI-guided decision support for managing pancreatic conditions
This project will test an AI tool that reads contrast-enhanced CT scans to help doctors decide whether people with suspected pancreatic disease need surgery, close monitoring, or routine follow-up.
-
Laparoscopic versus open pancreaticoduodenectomy outcomes
This trial will test whether laparoscopic (keyhole) pancreaticoduodenectomy leads to fewer complications and faster recovery than open pancreaticoduodenectomy in adults with resectable pancreatic or periampullary tumors.
-
Near‑total debulking surgery versus non‑surgical management for metastatic pancreatic neuroendocrine tumours
This study will test whether removing most of the tumour (near‑total debulking surgery) helps adults with stage 4 non‑functional pancreatic neuroendocrine tumours live longer or feel better compared with not doing debulking.
-
Personalized mRNA vaccine for advanced endocrine tumors
This study is testing a personalized mRNA vaccine to see if it can help patients with advanced endocrine tumors who haven't had success with standard treatments.
-
Creating personalized 3D models of pancreatic neuroendocrine tumors
This study is trying to create personalized 3D models of pancreatic neuroendocrine tumors from patients' surgical samples to better understand the disease and test new treatments.
-
Early detection of pancreatic neuroendocrine tumors using blood tests
This study is testing a new blood test to see if it can help find pancreatic neuroendocrine tumors earlier than current methods in adults who have not yet received treatment.
-
Using chemotherapy after surgery for high-risk pancreatic neuroendocrine tumors
This study tests if a combination of two chemotherapy drugs can help prevent cancer from coming back in people who have had surgery for high-risk pancreatic neuroendocrine tumors.
-
Treatment of advanced tumors with belzutifan
This study is testing a new medication called belzutifan to see if it can help people with advanced tumors related to specific conditions feel better and respond to treatment.
-
Gene modified immune cells for treating advanced melanoma and metastatic solid tumors
This study is testing if modified immune cells can safely target and attack advanced melanoma and other solid tumors in patients after they receive chemotherapy.
Related topics
Quick answers
How many Pancreatic Neuroendocrine Tumor clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 25 countries. The most sites are in China (4 trials), United States (3 trials), Italy (2 trials), Sweden (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.